Nature5 年
Developing isogenic cell models with CRISPR: an EML4-ALK fusion NSCLC cell line
We employed the CRISPR/Cas9 genome editing platform for the generation of the desired targeted genomic rearrangement in the A549 lung cancer ... a dose-response based assay monitored via IncuCyte ...